Stay updated with breaking news from Timothye Morris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report) Director Timothy E. Morris acquired 12,000 shares of DBV Technologies stock in a transaction dated Friday, August 25th. The shares were bought at an average cost of $1.52 per share, for a total transaction of $18,240.00. Following the completion of the purchase, the director now directly owns […]
MELBOURNE, Australia, May 17, 2023 -- Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced... | May 17, 2023
MELBOURNE, Australia, May 08, 2023 -- Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced... | May 8, 2023
MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today
Montrouge, France, October 3, 2022 DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors DBV Technologies